Indivior PLC (LON:INDV - Get Free Report) shares crossed above its 50-day moving average during trading on Friday . The stock has a 50-day moving average of GBX 874.95 ($11.77) and traded as high as GBX 1,070 ($14.39). Indivior shares last traded at GBX 1,047 ($14.08), with a volume of 441,402 shares traded.
Indivior Stock Performance
The stock's 50 day moving average price is GBX 874.95 and its two-hundred day moving average price is GBX 852.87. The firm has a market capitalization of £1.64 billion, a PE ratio of -868.11, a PEG ratio of -5.57 and a beta of 0.19. The company has a current ratio of 0.83, a quick ratio of 1.52 and a debt-to-equity ratio of -170.06.
Insider Buying and Selling
In related news, insider Juliet Thompson purchased 3,850 shares of the firm's stock in a transaction on Wednesday, June 11th. The shares were bought at an average price of GBX 1,388 ($18.67) per share, for a total transaction of £53,438 ($71,863.91). 3.44% of the stock is owned by company insiders.
About Indivior
(
Get Free Report)
Indivior PLC, together with its subsidiaries, engages in the development, manufacture, and sale of buprenorphine-based prescription drugs for the treatment of opioid dependence and co-occurring disorders in the United States, the United Kingdom, and internationally. The company develops medicines to treat substance use disorders, serious mental illnesses, and opioid overdose.
Read More
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Indivior, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Indivior wasn't on the list.
While Indivior currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Which stocks are hedge funds and endowments buying in today's market? Enter your email address and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying now.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
